RATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. It may also help doctors learn how patients respond to treatment. PURPOSE: This laboratory study is collecting, analyzing, and storing tissue samples from patients with non-Hodgkin's lymphoma.
OBJECTIVES: * Establish a central lymphoma tissue repository of fresh snap-frozen tissue from patients with previously untreated non-Hodgkin's lymphoma (NHL). * Determine a standard set of procedures for routine acquisition, banking, and study of these tissue samples. * Correlate presently activated phenotyping studies and future projected molecular studies of the DNA and RNA status of these tissue samples with clinical results. * Correlate pretreatment phenotype or genotype of tissue samples from patients with intermediate- or high-grade NHL with patient outcome, in terms of complete response rate, time to progression, and survival. * Correlate the lymphoma lineage (T-cell vs B-cell), loss of class II human histocompatibility antigen status (HLA-DR-positive vs HLA-DR-negative), proliferative index (as measured by Ki-67), and B- or T-cell antigen aberrancy (e.g., lack of Pan B or T antigen expression) with outcome in patients with intermediate- or high-grade NHL. OUTLINE: Patients are treated on the SWOG study on which they are enrolled. Tissue samples obtained before treatment began are banked in a tissue repository. Samples from patients with intermediate- or high-grade non-Hodgkin's lymphoma are analyzed by three-stage immunohistochemistry using monoclonal antibodies to B-cell antigens, T-cell antigens, immunoglobulins, CALLA, HLA-DR, anti-interleukin-2 receptor, and Ki-67 (for the proliferative index). Phenotype (immune marker status, proliferation status, and activation status) is correlated with response to treatment, relapse, and overall survival. PROJECTED ACCRUAL: Approximately 495 patients will be accrued for this study.
Study Type
OBSERVATIONAL
Enrollment
458
Establishment of a central lymphoma tissue repository of fresh snap-frozen tissue from patients with previously untreated non-Hodgkin's lymphoma (NHL)
feasibility of collecting specimens
Time frame: July 2011
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Alaska Regional Hospital Cancer Center
Anchorage, Alaska, United States
Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
Peninsula Medical Center
Burlingame, California, United States
North Bay Cancer Center
Fairfield, California, United States
California Pacific Medical Center - California Campus
San Francisco, California, United States
Sutter Health - Western Division Cancer Research Group
San Rafael, California, United States
Sutter Solano Medical Center
Vallejo, California, United States
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Tampa, Florida, United States
Piedmont Hospital
Atlanta, Georgia, United States
...and 181 more locations